Cen Biotech
(OTC) CENBF
Cen Biotech Financials at a Glance
Market Cap
$6,400
Revenue (TTM)
$619.83K
Net Income (TTM)
$741.54K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.00
Volume
4
Open
$0.00
Price
$0.00
Volume
4
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.00
Volume
4
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
CENBF News
CENBF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cen Biotech
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
Brian S. Payne
Website
www.cenbiotechinc.comHeadquarters
Windsor, ON N8T 3R9, CA
CENBF Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
60%
Return on Assets
-19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.40K
Shares Outstanding
64.13M
Volume
4
Short Interest
0.00%
Avg. Volume
420.1
Financials (TTM)
Gross Profit
$498.00K
Operating Income
$1.26M
EBITDA
$773.00K
Operating Cash Flow
$335.50K
Capital Expenditure
$129.53K
Free Cash Flow
$465.04K
Cash & ST Invst.
$83.60K
Total Debt
$5.23M
Cen Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$65.23K
-52.0%
Gross Profit
$65.23K
+200.3%
Gross Margin
100.00%
N/A
Market Cap
$6.40K
N/A
Market Cap/Employee
$1.60K
N/A
Employees
4
N/A
Net Income
$371.46K
+192.9%
EBITDA
$409.91K
+356.0%
Quarterly Fundamentals
Net Cash
$4.56M
-281.5%
Accounts Receivable
$114.74K
+151.3%
Inventory
$0.00
N/A
Long Term Debt
$121.87K
-35.9%
Short Term Debt
$4.85M
+321.2%
Return on Assets
-19.28%
N/A
Return on Invested Capital
59.82%
N/A
Free Cash Flow
$396.81K
+540.2%
Operating Cash Flow
$432.12K
+579.4%